AzTrials
AzTrials

Pediatric AnxietyNCT07761637

Non-Wearable Audiovisual Distraction for Children's Medical Anxiety in the ED

A study testing Non-Wearable Audiovisual Distraction and Routine ED Care in people with Pediatric Anxiety, run by National Taiwan University Hospital at 1 site in Taiwan.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Pediatric emergency department (ED) visits often cause significant anxiety and stress for young patients due to unfamiliar environments and invasive medical procedures. Non-pharmacological interventions, such as distraction, are vital for reducing pediatric anxiety and improving procedural outcomes. Read more about this study

Who is it for?
Ages 6 to 12 years
Conditions the study is for
Pediatric Anxiety
What is being tested?
Non-Wearable Audiovisual Distraction and Routine ED Care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteTaiwan
Study dates
1 Sep 2026to 30 Sep 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Pediatric patients aged 6 to 12 years presenting to the Emergency Department.
  • Requiring invasive medical procedures (e.g., blood sampling, intravenous line insertion, or laceration repair/suturing).
  • Patient and legal guardian/parent willing and able to provide informed assent/consent and comply with study protocols.

Who cannot join

  • Patients with severe developmental delay, cognitive impairment, or neurological disorders affecting communication or behavioral assessment.
  • Patients with severe visual or hearing impairment that prevents interaction with the non-wearable display system.
  • Hemodynamically unstable patients or those requiring immediate life-saving resuscitation.
  • Patients with severe upper body or facial injuries that prevent the placement or operation of continuous ECG recorders.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Taiwan1 site
  • National Taiwan University Hospital Yunlin Branch

    Douliu, Yunlin County, 640203

    Nai-Yun Chang, MD, +886-972-655-205, gigi06060606@gmail.com

Other trials in Taiwan

About this study

Official title: Effectiveness of Non-Wearable Immersive Audiovisual Distraction in Alleviating Pediatric Anxiety in Emergency Department: A Stratified Randomized Controlled Trial

Pediatric emergency department (ED) visits often cause significant anxiety and stress for young patients due to unfamiliar environments and invasive medical procedures. Non-pharmacological interventions, such as distraction, are vital for reducing pediatric anxiety and improving procedural outcomes.

This study evaluates the effectiveness of a non-wearable, immersive audiovisual distraction system (LG StanbyME display) in alleviating pediatric anxiety during emergency department care, compared to standard care.

Read more

The main questions it aims to answer are:

Does non-wearable audiovisual distraction reduce anxiety levels in pediatric emergency patients compared to standard care?

Does the intervention improve physiological indicators of distress, such as Heart Rate Variability (HRV)?

Participants will:

Be randomly assigned to either the non-wearable audiovisual distraction group or the routine care group.

Undergo continuous physiological monitoring (HRV) and clinical anxiety assessment (mYPAS-SF) during their ED visit.

Read the detailed description

Pediatric anxiety in emergency settings can lead to uncooperative behavior, prolonged procedure times, and long-term medical fear. Traditional Virtual Reality (VR) headsets often face clinical limitations in pediatric EDs, such as user discomfort, sanitation challenges, and restricted head/eye movement.

To address these barriers, this stratified randomized controlled trial (RCT) introduces a non-wearable, highly mobile immersive display system (LG StanbyME) combined with interactive soothing content and digital companionship.

Pediatric patients aged 3 to 12 years presenting to the Emergency Department of National Taiwan University Hospital Yunlin Branch will be screened for eligibility. Eligible participants will be randomized into two arms:

Experimental Group: Receives non-wearable immersive audiovisual distraction via the mobile display during ED waiting and procedural periods.

Control Group: Receives standard pediatric ED care without digital distraction devices.

Primary outcomes include objective autonomic nervous system activity evaluated through continuous Heart Rate Variability (HRV) monitoring using a wearable ECG recorder (QOCA ecg103). Secondary outcomes include subjective pediatric anxiety scores assessed via the Modified Yale Preoperative Anxiety Scale-Short Form (mYPAS-SF), parental anxiety, and staff satisfaction.

Being tested
Non-Wearable Audiovisual Distraction, Routine ED Care
Keywords
Audiovisual Distraction, Pediatric Emergency Medicine, Heart Rate Variability, Non-Wearable Technology, mYPAS-SF, Procedural Pain and Anxiety
Medical subject headings
Pain, Procedural, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Non-Wearable Audiovisual DistractionBehavioural

    Implementation of a non-wearable mobile display system (LG StanbyME) providing gentle, low-stimulation audiovisual distraction and digital companionship to alleviate pediatric procedural anxiety.

  • Routine ED CareOther

    Standard pediatric emergency department care according to clinical guidelines without digital distraction devices.

Study groups in NCT07761637
Study groupRoleWhat they receive
Audiovisual Distraction GroupExperimentalPediatric patients receive non-wearable immersive audiovisual distraction via a mobile display (LG StanbyME presenting low-stimulation, guided soothing videos and simple interactive games) during emergency department procedures.
Receives: Behavioral: Non-Wearable Audiovisual Distraction
Routine Care GroupActive comparatorPediatric patients receive standard emergency department care without additional digital audiovisual distraction devices.
Receives: Other: Routine ED Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in Heart Rate Variability High-Frequency Power (HF-HRV)

    Continuous measurement of parasympathetic autonomic activity evaluated via HF power in normalized units (nu) or $ms^2$

    Measured: Continuously measured from baseline (wait time, T0) through procedural period (T1/T2) up to 30 minutes post-procedure (recovery period, T3).

  2. Changes in Heart Rate Variability LF/HF Ratio

    Autonomic nervous system balance assessed via the ratio of Low-Frequency to High-Frequency power.

    Measured: Continuously measured from baseline (wait time, T0) through procedural period (T1/T2) up to 30 minutes post-procedure (recovery period, T3).

  3. Changes in Heart Rate Variability RMSSD

    Short-term parasympathetic modulation evaluated via Root Mean Square of Successive Differences (RMSSD) in milliseconds (ms).

    Measured: Continuously measured from baseline (wait time, T0) through procedural period (T1/T2) up to 30 minutes post-procedure (recovery period, T3).

Secondary outcomes (1)
  1. Pediatric Observational Anxiety Score (mYPAS-SF)

    Behavioral anxiety score assessed using the Modified Yale Preoperative Anxiety Scale-Short Form (mYPAS-SF). The tool evaluates 4 categories (activity, vocalization, emotional expressiveness, and state of arousal), yielding a total score ranging from 22.9 to 100, where higher scores indicate greater procedural anxiety.

    Measured: Assessed at baseline (pre-procedure) and immediately post-procedure.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Aug 2026
  2. Study start1 Sep 2026 (estimated)
  3. Primary completion31 Aug 2027 (estimated)
  4. Study completion30 Sep 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are randomly assigned into two parallel groups: Non-Wearable Audiovisual Distraction Group or Routine Care Group.
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07761637
Sponsor's protocol ID
202601226RINE
Status last verified
Jul 2026
First submitted
2 Aug 2026
Last updated
12 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified individual participant data, including demographic characteristics (age, sex), baseline and post-procedural mYPAS-SF scores, and time-domain/frequency-domain Heart Rate Variability (HRV) parameters (HF, LF/HF ratio, RMSSD), will be shared with qualified researchers upon reasonable request.

Questions about this trial

What is this clinical trial studying?

A study testing Non-Wearable Audiovisual Distraction and Routine ED Care in people with Pediatric Anxiety, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 12 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nai-Yun Chang, MD (+886-972-655-205, gigi06060606@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in Heart Rate Variability High-Frequency Power (HF-HRV) (time frame: Continuously measured from baseline (wait time, T0) through procedural period (T1/T2) up to 30 minutes post-procedure (recovery period, T3).). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in